Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Nimodipine Dispersible Tablets

Approval Number

国药准字H20000235

Company金花企业（集团）股份有限公司西安金花制药厂

Registration Date

July 2, 2020

Previous Approval Numbers

国药准字H20000235

Drug Information

Generic Name

尼莫地平分散片

Brand Name

金花

Dosage Form

片剂(分散)

Strength

20mg

Drug Type

化学药品

Registration Date

July 2, 2020

Company Information

Applicant Company

Company Name金花企业（集团）股份有限公司西安金花制药厂

Manufacturing Company

Company Name金花企业（集团）股份有限公司西安金花制药厂

Company Address

西安市高新技术产业开发区科技四路202号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

尼莫地平分散片 - NMPA 批准文号 | MedPath